Literature DB >> 21136565

Preoperative inflammation is a prognostic factor for gallbladder carcinoma.

H-S Han1, J Y Cho, Y-S Yoon, K S Ahn, H Kim.   

Abstract

BACKGROUND: Inflammation frequently accompanies gallbladder carcinoma (GBC), but its impact on outcome is unclear. The present study investigated the impact of concomitant inflammation on survival of patients with GBC.
METHODS: All patients undergoing surgery for GBC between October 2003 and May 2009 were identified retrospectively from a prospectively collected database. Patients were classified according to whether preoperative inflammation was present (65 patients) or not (23).
RESULTS: A total of 88 patients were enrolled. There were no differences in sex, mean age, tumour node metastasis (TNM) stage and radicality of resection between the two groups. The overall 3-year survival rate was lower in patients with preoperative inflammation than in those without (33 versus 73 per cent; P = 0·001). In univariable analysis, preoperative inflammation, T, N and M category, TNM stage, radicality of surgery and tumour differentiation were significant prognostic factors. The presence of preoperative inflammation (hazard ratio (HR) 2·38, 95 per cent confidence interval 1·04 to 5·43), lymph node metastases (HR 5·23, 1·05 to 26·09) and R1 or R2 resection (HR 3·77, 1·47 to 9·72) were independent prognostic factors for poor survival.
CONCLUSION: The presence of preoperative inflammation is an independent prognostic factor for poor survival in patients with GBC.
Copyright © 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21136565     DOI: 10.1002/bjs.7265

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  Preoperative cholangitis and metastatic lymph node have a negative impact on survival after resection of extrahepatic bile duct cancer.

Authors:  Jai Young Cho; Ho-Seong Han; Yoo-Seok Yoon; Dae Wook Hwang; Kyuwhan Jung; Ji Hoon Kim; Yujin Kwon; Haeryoung Kim
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

2.  The role of H. pylori infection in gall bladder cancer: clinicopathological study.

Authors:  Ehsan Hassan Hassan; Shawkat S Gerges; Kamal A El-Atrebi; Hala T El-Bassyouni
Journal:  Tumour Biol       Date:  2015-04-16

Review 3.  Key factors influencing prognosis in relation to gallbladder cancer.

Authors:  Charles Henry Caldow Pilgrim; Ryan T Groeschl; Kiran K Turaga; T Clark Gamblin
Journal:  Dig Dis Sci       Date:  2013-05-22       Impact factor: 3.199

Review 4.  Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta-analysis.

Authors:  Kui Sun Choi; Sae Byeol Choi; Pyoungjae Park; Wan Bae Kim; Sang Yong Choi
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

5.  Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.

Authors:  Lingqiang Zhang; Ruitao Wang; Wei Chen; Xinsen Xu; Shunbing Dong; Haining Fan; Chang Liu
Journal:  HPB (Oxford)       Date:  2016-05-06       Impact factor: 3.647

6.  Postoperative complications influence prognosis and recurrence patterns in periampullary cancer.

Authors:  Jai Young Cho; Ho-Seong Han; Yoo-Seok Yoon; Dae Wook Hwang; Kyuwhan Jung; Young Ki Kim
Journal:  World J Surg       Date:  2013-09       Impact factor: 3.352

7.  Practical guidelines for the surgical treatment of gallbladder cancer.

Authors:  Seung Eun Lee; Kyung Sik Kim; Wan Bae Kim; In-Gyu Kim; Yang Won Nah; Dong Hee Ryu; Joon Seong Park; Myung Hee Yoon; Jai Young Cho; Tae Ho Hong; Dae Wook Hwang; Dong Wook Choi
Journal:  J Korean Med Sci       Date:  2014-10-08       Impact factor: 2.153

Review 8.  Tackling Surgical Morbidity and Mortality through Modifiable Risk Factors in Cancer Patients.

Authors:  Boram Lee; Ho-Seong Han
Journal:  Nutrients       Date:  2022-07-28       Impact factor: 6.706

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.